MSD and Moderna have kicked off another phase 3 trial of their personalised cancer vaccine V940 used alongside MSD's PD-1 inhibitor Keytruda, this time focusing on patients with earlier-stage non ...

The rivalry between Pfizer and MSD in pneumococcal vaccines has dialled up a notch with the FDA approval of MSD’s new shot Capvaxive, the first to be aimed specifically at adults. The 21-valent ...

The most powerful and modular diffusion model GUI, api and backend with a graph/nodes interface.

In this paper, we propose an efficient, fast, versatile and LoRA-compatible distillation method to accelerate the generation of pre-trained diffusion models: Flash Diffusion. The method reaches ...

Use precise geolocation data and actively scan device characteristics for identification. This is done to store and access ...